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Dysregulation of Diurnal Rhythms of Serotonin 5-HT2C and
Corticosteroid Receptor Gene Expression in the Hippocampus with
Food Restriction and Glucocorticoids
Megan C. Holmes, Karen L. French, and Jonathan R. Seckl
Molecular Endocrine Laboratory, Molecular Medicine Centre, University of Edinburgh, Western General Hospital,
Edinburgh EH4 2XU, Scotland, United Kingdom
Both serotonergic dysfunction and glucocorticoid hypersecre-
tion are implicated in affective and eating disorders. The ad-
verse effects of serotonergic (5-HT)2C receptor activation on
mood and food intake, the antidepressant efficacy of 5-HT2
receptor antagonists, and the hyperphagia observed in 5-HT2C
receptor knockout mice all suggest a key role for increased
5-HT2C receptor-mediated neurotransmission. Glucocorticoids,
however, downregulate 5-HT2C receptor mRNA in the hip-
pocampus, and it is unclear how increased 5-HT2C receptor
sensitivity is achieved in the presence of elevated glucocorti-
coid levels in depression. Here we show a monophasic diurnal
rhythm of 5-HT2C receptor mRNA expression in the rat hip-
pocampus that parallels time-dependent variations in 5-HT2C
receptor agonist-induced behaviors in open field tests. Rats
entrained to chronic food restriction show marked but intermit-
tent corticosterone hypersecretion and maintain an unaltered
5-HT2C receptor mRNA rhythm. The 5-HT2C receptor mRNA
rhythm, however, is suppressed by even modest constant ele-
vations of corticosterone (adrenalectomy 1 pellet) or with ele-
vated corticosterone during the daytime (8 A.M.), whereas a
normal rhythm exists in animals that have the same dose of
corticosterone in the evening (6 P.M.). Thus, animals showing
even a transient daytime corticosterone nadir exhibit normal
hippocampal 5-HT2C receptor mRNA rhythms, even in the
presence of overt corticosterone hypersecretion. Chronic food
restriction also abolishes the normal diurnal variation in hip-
pocampal glucocorticoid receptor (GR) and mineralocorticoid
receptor mRNAs and produces, unusually, both elevated cor-
ticosterone and increased GR. The mismatch between elevated
glucocorticoids and maintained 5-HT2C receptor and increased
GR gene expression in the hippocampus provides a new model
to dissect mechanisms that may underlie affective and eating
disorders.
Key words: 5-HT2C receptor; serotonin; corticosterone; diur-
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Abnormalities of both serotonergic (5-HT) neurotransmission
and hypothalamic-pituitary-adrenal (HPA) axis activity are found
in depression and eating disorders and may play important patho-
genic roles. Both conditions are frequently associated with ele-
vated plasma cortisol levels (Carroll et al., 1976) and insensitivity
to glucocorticoid (dexamethasone) feedback (Carroll, 1982), pre-
sumed to be caused by increased central drive on the HPA axis.
Abnormal 5-HT neurotransmission is also believed to be a key
factor in depression (Meltzer and Lowy, 1987). Many clinically
efficacious antidepressants alter 5-HT neurotransmission, improv-
ing both mood and hypercortisolemia (Ogren et al., 1979;
Linkowski et al., 1987).
Glucocorticoids act via intracellular high-affinity mineralocor-
ticoid receptors (MRs) and lower-affinity glucocorticoid receptors
(GRs) (Reul and de Kloet, 1985; McEwen et al., 1986). In con-
trast, 5-HT binds to a number of distinct cell membrane sites
(Peroutka, 1993). The hippocampus has a dense 5-HT innerva-
tion, highly expresses both corticosteroid and 5-HT receptors
(Palacios et al., 1990; de Kloet, 1991; Wright et al., 1995), and is
an important locus for the interaction of the two systems. Sero-
tonin is important for the maintenance of corticosteroid receptor
gene expression in the hippocampus (Seckl et al., 1990; Yau et al.,
1994). Similarly, glucocorticoids alter hippocampal expression of
at least two 5-HT receptor subtypes, 5-HT1A (Chalmers et al.,
1993; Zhong and Ciaranello, 1995) and 5-HT2C (Holmes et al.,
1995b). 5-HT1A and 5-HT2C receptors are excellent candidates to
mediate functional abnormalities in depression and both are
highly expressed in the hippocampus (Mengod et al., 1990;
Chalmers and Watson, 1991). Sets of antidepressant drugs act on
each receptor (Robinson, 1993), and both are implicated in HPA
regulation (Fuller, 1992). m-Chlorophenylpiperazine (mCPP),
which binds to 5-HT2C receptors with high affinity, increases
plasma glucocorticoid levels, reduces food intake (Blundell, 1992;
Clifton et al., 1993), attenuates locomotion, and exerts dysphoric
effects in some depressive illnesses (JosephVanderpool et al.,
1993; Jacobsen et al., 1994), whereas 5-HT2C (and -2A) receptor
antagonists (e.g., ketanserin and ritanserin) are clinically effica-
cious antidepressants (Robinson, 1993).
The mRNAs encoding 5-HT2C receptors, GR, and MR, but not
5-HT1A receptors, exhibit a circadian rhythm in the hippocampus
(Herman et al., 1993; Holmes et al., 1995a,b). Affective disorders
are frequently associated with blunting (elevation) of the normal
afternoon/evening nadir of the cortisol circadian rhythm
(Linkowski et al., 1987). Central 5-HT activity also shows a diur-
nal rhythm, with higher 5-HT release in the hippocampus during
the active period (darkness in rats) (Kale´n et al., 1989). Other
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diurnal functions (e.g., sleep, psychological performance) are also
disrupted in depression (Healy, 1987), and clearly, diurnally vary-
ing processes underlying the interaction between 5-HT and cor-
tisol may be important to understanding abnormal central mech-
anisms in affective disorders (Moffoot et al., 1994). In previous
work we found that the rhythm of hippocampal 5-HT2C receptor
gene expression was maintained in adrenalectomized rats
(Holmes et al., 1995b) but suppressed by chronic stress-mediated
elevations of plasma corticosterone (Holmes et al., 1995a), pre-
sumably an adaptive process to attenuate sensitivity of this recep-
tor with chronic stress. To investigate further the diurnal cues
regulating hippocampal receptor expression, a food restriction
paradigm (Krieger and Hauser, 1978) was used that alters the
plasma corticosterone rhythm as well as feeding and locomotor
behavior, leaving only the light–dark cues unchanged.
In this study we wished to determine (1) the control of corti-
costeroid and serotonin receptor mRNA expression in the hip-
pocampus throughout the 24 hr period, (2) any link between
diurnal hippocampal 5-HT2C receptor mRNA changes and pos-
sible diurnal rhythms in 5-HT2C receptor-mediated behaviors, and
(3) the role of diurnal glucocorticoid effects and food restriction
(a chronic intermittent and perhaps pathophysiologically relevant
stressor) on the diurnal patterns of receptor gene expression.
MATERIALS AND METHODS
Behavioral experiments
Open field behavior in response to mCPP. Male Han–Wistar rats were
given mCPP (1 mg/kg, i.p.; Sigma, St. Louis, MO) or saline 30 min before
testing in the open field (novel environment). Animals were placed in a
large Perspex box (60 3 40 cm) divided into eight zones for 5 min. The
number of times the rat crossed into a new zone and the number of
rearings were recorded. Animals (six to eight per group) were tested at 9
A.M., 1 P.M., or 5 P.M.
Inhibition of food intake in response to mCPP. Sixteen rats (;300 gm)
were housed singly in a light-controlled environment (lights on from 7
A.M. to 7 P.M.). To test the feeding response to the 5-HT2C receptor
agonist, animals were fasted overnight, and then 30 min after an intra-
peritoneal injection of saline or mCPP (1 mg/kg), the amount of food
ingested over a 1 hr period was determined. mCPP or saline were given
in a random design, spaced 1 week apart at 9 A.M. and 1, 5, and 9 P.M.
Food restriction
Han–Wistar rats (;250 gm) were housed in pairs and handled daily for
1 week before the study. Lights were on from 7 A.M. to 7 P.M. For food
restriction studies, rats were allowed access to food pellets only between
10 A.M. and noon. Water was available ad libitum. The animals were
entrained to the food restriction regimen for 3 weeks before they were
killed. Controls had tap water and rat chow available ad libitum. On the
day of the experiment, four control and four food-restricted animals were
decapitated every 4 hr throughout a 24 hr period (n 5 8 at 8 P.M. and
midnight). Care was taken to cause minimal stress to the rats before
decapitation, which was completed within 1 min of disturbing a cage.
Trunk blood was collected, and brains were removed, frozen on dry ice,
and stored at 280°C. Cryostat sections (10 mm) were cut at the level of
the posterior hippocampus (approximately Bregma 24.80 mm; Paxinos
and Watson, 1986). Sections were thaw-mounted onto gelatin-subbed,
poly-L-lysine-coated slides and stored at 280°C, ready for in situ hybrid-
ization histochemistry.
Adrenalectomy and constant corticosterone replacement
Food restriction caused two peaks in plasma corticosterone (the normal
diurnal evening peak and an additional morning peak at the normal
nadir). To determine whether these changes in corticosterone were
responsible for alterations in gene expression, animals were bilaterally
adrenalectomized by the dorsal approach under halothane anesthesia,
and a continuous-release corticosterone pellet (100 mg, 60-day release
pellet; Innovative Research of America, Toledo, OH) was inserted sub-
cutaneously to produce constant corticosterone levels approximating the
24 hr mean. Sham-operated animals were given a placebo pellet. Animals
were allowed to recover from anesthesia and placed in cages in pairs (with
0.9% saline to drink for the adrenalectomized rats) for 7 d before they
were killed at either 8 A.M. or 8 P.M. Groups contained five to six
animals.
Adrenalectomy and pulsatile corticosterone replacement
To determine whether the timing of the corticosterone peak was impor-
tant in the regulation of hippocampal receptor gene expression, rats were
adrenalectomized and given corticosterone injections (20 mg/kg, s.c., in
200 ml of corn oil for 7 d) at various times of day. One group received
corticosterone injections at 8 A.M., the normal diurnal nadir of cortico-
sterone. Another group received corticosterone at 6 P.M. to reproduce
the normal elevation of plasma corticosterone levels at the onset of the
dark phase. Controls were sham adrenalectomized and received 200 ml of
corn oil daily. Rats (four per group) were killed at 8–10 A.M., 2–4 P.M.,
and 8–10 P.M.; the brains were removed and processed for in situ
hybridization histochemistry, as above.
5-HT and GR subtype in situ hybridization histochemistry
In situ hybridization histochemistry was performed as described previ-
ously (Seckl et al., 1990; Yau et al., 1994). In brief, sections were
post-fixed in 4% paraformaldehyde and washed in 23 SSC. For 5-HT
receptor subtype mRNA detection, sections were prehybridized with
buffer for 2 hr at 50°C; sections for GR and MR mRNA detection were
hybridized directly. [35S]UTP-labeled mRNA antisense probes were tran-
scribed in vitro from linearized plasmids of rat 5-HT1A receptor cDNA
(Albert et al., 1990) and 5-HT2C receptor cDNA (Julius et al., 1988), GR,
and MR cDNA as described previously (Seckl et al., 1990). Probes
(10–20 3 106 counts/ml) were denatured, added to hybridization buffer,
applied to sections, hybridized, and washed under stringent conditions, as
reported previously (Seckl et al., 1990). Slides were dipped in Kodak
NTB2 emulsion, exposed at 4°C for 4 weeks, developed, and counter-
stained (1% pyronin). Expression was quantified by counting silver grains
overlying identified neurons under bright-field illumination using a
computer-driven image analysis system (Seescan, Cambridge, UK) and
rate-of-change filters (Aldridge and Seckl, 1993). Expression was esti-
mated over at least 15 cells per subfield for each animal. Specificity was
demonstrated using 35S-labeled “sense” RNA probes of similar specific
activity, hybridized under identical conditions. No specific cellular hybrid-
ization signal was seen with any sense probe (data not shown; but see
Seckl et al., 1990).
Plasma corticosterone measurements
Corticosterone was measured in trunk blood samples by specific radio-
immunoassay, as described previously (MacPhee et al., 1989) with anti-
serum donated by Dr. C. Kenyon, Edinburgh. The detection limit of the
assay was 6 nmol/l.
Statistical analysis
For the in situ hybridization results, the average number of grains counted
over each hippocampal area was standardized for each experiment as
percentage grains of the 8 P.M. control group (n 5 4–6 per group). All
results were analyzed by a one- or two-way ANOVA, followed by Dun-
nett’s post hoc test. Significance levels were taken as p , 0.05. For the
mCPP-induced effects, the drug group was compared with the control
group at each time of day using a t test (n 5 6–8).
RESULTS
Circadian rhythm of hippocampal 5-HT2C receptor
mRNA expression and 5-HT2C receptor agonist-
induced behavior
A diurnal rhythm of 5-HT2C receptor mRNA expression was seen
in the ventral CA1 region of the hippocampus (Fig. 1A) as well as
dorsal CA1 and subiculum. When 5-HT2C receptor agonist-
induced behavior was compared at different times of day, a
diurnal rhythm in agonist effectiveness was apparent (Fig. 1B,C).
In the open field test, mCPP significantly inhibited the locomotor
activity of the rats, as determined by the number of crossings of
the open field zones, at 9 A.M. but not at 1 or 5 P.M. (Fig. 1B).
Similarly, the number of rearings was significantly reduced in the
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mCPP-treated animals at 9 A.M. and 1 P.M., but not at 5 P.M.
(Fig. 1C); however, there was no effect of time of day on the
efficacy of mCPP to inhibit feeding (Fig. 1D).
The effect of food restriction on plasma corticosterone
and hippocampal receptor gene expression
Body weight and food intake
During the 3 week period of the food restriction experiment, the
control rats increased their weight by 16%, whereas the animals
fed for only 2 hr/d maintained their initial body weight. The food
intake per day was 14 6 1 gm for the animals on food restriction
compared with 22 6 1 gm for the control rats fed ad libitum.
Plasma corticosterone
In control animals, plasma corticosterone showed a well defined
diurnal rhythm, with a nadir at 8 A.M.-noon and a peak at 8 P.M.
(Fig. 2). Chronic exposure to food restriction (food available only
from 10 A.M.-noon) produced a biphasic rhythm in plasma cor-
ticosterone, with a novel peak at 8 A.M. ( just before food avail-
ability) as well as the usual diurnal peak at 8 P.M. ( just after lights
off and at the beginning of the activity period). Food-restricted
rats, however, showed a plasma corticosterone nadir, although
delayed, at 4 P.M. (Fig. 2). The total 24 hr secretion of cortico-
sterone in food-restricted rats was significantly greater (94%
higher) than in controls with access to food ad libitum.
5-HT2C receptor mRNA expression
5-HT2C receptor mRNA expression, measured in various subre-
gions of the hippocampus at 4 hr intervals, exhibited a monopha-
sic rhythm in dorsal CA1, ventral CA1, and subiculum, peaking at
4–8 A.M. and falling to a nadir at 4 P.M. (Fig. 3A). The rhythm
in receptor expression is similar to the rhythm in plasma cortico-
sterone; however, it is shifted to the right (delayed) by 4–8 hr. In
contrast to plasma corticosterone, the rhythm in 5-HT2C receptor
gene expression in dorsal CA1, ventral CA1, and subiculum were
unaltered in food-restricted animals (Fig. 3A). No circadian
changes were seen in 5-HT2C receptor mRNA expression in CA3
in either group (data not shown).
5-HT1A receptor mRNA expression
No changes in 5-HT1A receptor mRNA expression were observed
over the 24 hr period in any region of the hippocampus measured
(Fig. 3B). Furthermore, food restriction exerted no effect on
Figure 1. Diurnal variation of 5-HT2C receptor mRNA expression and
mCPP-induced behaviors. A, 5-HT2C receptor mRNA expression in the
CA1 subregion of the hippocampus over a 24 hr period. Receptor mRNA
levels were determined by in situ hybridization histochemistry. The mean
number of grains /subregion /rat was standardized to the expression ob-
served in the control rats at 8 P.M. (20) (100%). Values represent mean 6
SEM; n 5 4. *p , 0.05 compared with 8 A.M. (8). B–D, Sensitivity to
mCPP-induced inhibition; B, locomotor behavior; C, rearings in an open
field. The % number of crossings of open field zones and % number of
rearings in a 5 min period after mCPP (1 mg/kg, i.p.) 30 min before
testing, compared with controls (saline injected) tested at the same time of
day. Numbers per group 5 6–8. D,The % inhibition of food intake 30 min
after mCPP (1 mg/kg, i.p.) compared with control animals tested at the
same time of day. Animals were fasted overnight before testing, and the
test period was for 1 hr. Number of animals per group 5 8. All columns
represent mean results per group 6SEM. *p , 0.05 compared with
controls tested at the same time of day. Time of day: 9 5 9 A.M.; 13 5 1
P.M.; 17 5 5 P.M.; 21 5 9 P.M.
Figure 2. Twenty-four hour profile of plasma corticosterone (Plasma B)
levels in control (F) and in animals after 3 week food restriction (M).
Values represent mean 6 SEM; n 5 4–8. o represents period of food
availability for food-restricted animals, and black bars represent period of
darkness. Time notation as in Figure 1 legend.
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5-HT1A receptor mRNA expression in the hippocampus (DG,
CA1, and subiculum) at any time of day (Fig. 3B).
MR mRNA expression
In control rats, hippocampal MR gene expression exhibited a
clear significant circadian rhythm, with a peak at 8 A.M. and a
nadir between midnight and 4 A.M., in both dentate gyrus and
CA1 neurons (Fig. 4A). No diurnal variation in MR mRNA was
found in CA3. After food restriction the rhythm of MR gene
expression was disrupted with a nonsignificant variance with time.
Within this, the peak MR mRNA expression was delayed until 4
P.M., although the nadir remained at midnight.
GR mRNA expression
There was also a clear significant diurnal rhythm of GR mRNA
expression in controls, again confined to the dentate gyrus and
CA1. The diurnal peak was at 8 A.M. and the nadir at midnight
(Fig. 4B). Food restriction altered the rhythms of GR mRNA in
both dentate gyrus and CA1, although significant variance with
respect to time of day persisted. In the dentate gyrus, the GR
mRNA peak shifted to 8 P.M., whereas in CA1 peaks at noon and
8 P.M. occurred (Fig. 4B), a biphasic pattern similar to plasma
corticosterone levels (correlation of GR mRNA changes with
plasma B changes; p 5 0.03). No significant changes in GR gene
expression were observed over time in the CA3 region of the
hippocampus in either group.
The effect of constant corticosterone levels on
circadian variations in hippocampal receptor
gene expression
In rats sham-adrenalectomized with placebo pellet, plasma corti-
costerone levels showed a normal circadian variation (low morn-
ing and high evening levels) (Fig. 5). Adrenalectomized rats with
100 mg corticosterone pellets had plasma corticosterone levels
modestly elevated over the control morning nadir but fixed
throughout the day (Fig. 5). Sham-adrenalectomized controls had
higher hippocampal 5-HT2C receptor mRNA expression at 8
A.M. than at 8 P.M. (Fig. 6a), as seen in the (unoperated) controls
in the first study; however, constant corticosterone levels abol-
ished the diurnal rhythm. Expression was fixed at levels similar to
the 5-HT2C receptor mRNA nadir at 8 P.M., most notably in
ventral CA1 and the subiculum. Similarly, the normal diurnal
variation in MR and GR gene expression in the hippocampus was
lost in animals with constant corticosterone levels (Fig. 6c,d). GR
Figure 3. Twenty-four hour profile of (A)
5-HT2C and (B) 5-HT1A receptor mRNA
expression in control (m) and food-
restricted animals () in various hippocam-
pal subregions. Receptor mRNA levels
were determined by in situ hybridization his-
tochemistry. The mean number of grains /
subregion /rat was standardized to the ex-
pression observed in the control rats at 8
P.M. (20) (100%). Values represent
mean 6 SEM; n 5 4. *p , 0.05 compared
with peak value. Time notation as in Figure
1 legend.
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mRNA levels approximated the evening diurnal nadir with con-
stant corticosterone, whereas MR mRNA expression was not
clearly repressed, although diurnal variation was absent. No dif-
ferences were observed in 5-HT1A receptor mRNA expression in
the hippocampus of any group (Fig. 6b).
The effect of pulsatile corticosterone on hippocampal
5-HT2C receptor mRNA expression
To examine the possibility that the absence of a double diurnal
peak in hippocampal 5-HT2C receptor gene expression in parallel
to plasma corticosterone in food-restricted rats might reflect an-
ergy of the response to elevated glucocorticoids in the morning,
corticosterone was administered by injection in the morning and
at the normal diurnal peak (evening). Injection of corticosterone
produced elevated plasma corticosterone for 12 hr (Fig. 7). Cor-
ticosterone injection at 8 A.M. resulted in a constant level of
5-HT2C receptor gene expression throughout the day in all hip-
pocampal subfields (CA1 data shown in Fig. 7B). In contrast,
injection of corticosterone at 6 P.M., just before lights off, pro-
duced a rise in 5-HT2C receptor mRNA expression in CA1 (Fig.
7C) and subiculum (not shown) at 8 A.M., similar to that in
sham-adrenalectomized (Fig. 7A) and other control animals.
Variations of 5-HT2C receptor mRNA expression at
extra-hippocampal sites
To determine whether the circadian variation is specific to the
hippocampus, 5-HT2C receptor gene expression was also deter-
mined in other areas of the brain. 5-HT2C receptor mRNA ex-
pression was measured at 8 A.M. and 8 P.M. in the suprachias-
matic nucleus (SCN), preoptic area, bed nucleus of the stria
terminalis (BNST), retrosplenic granule cortex, paraventricular
nucleus of the hypothalamus (PVN), ventromedial nucleus, dor-
somedial nucleus, lateral hypothalamus, and amygdala. Most
areas did not show any variation of expression with time of day.
The two exceptions were the BNST, which like the hippocampus
had higher 5-HT2C receptor gene expression at 8 A.M., and the
PVN, which had an opposite rhythm, showing higher expression at
8 P.M. (Fig. 8).
Figure 4. Twenty-four hour profile of (A)
MR and (B) GR mRNA expression in
control (f) and food-restricted () ani-
mals in various hippocampal subregions.
Receptor mRNA levels were determined
by in situ hybridization histochemistry.
The mean number of grains /subregion /rat
was standardized to the expression ob-
served in the control rats at 8 P.M. (20)
(100%). Values represent mean 6 SEM;
n 5 4. *p , 0.05 compared with peak
value. Time notation as in Figure 1 legend.
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DISCUSSION
Circadian expression of hippocampal 5-HT2C receptor
mRNA and 5-HT2C receptor agonist-mediated behavior
This study confirms and extends our previous observation of
higher 5-HT2C receptor mRNA expression in discrete subregions
of the hippocampus in the morning (Holmes et al., 1995a) to show
a clear monophasic diurnal rhythm of 5-HT2C receptor gene
expression. To determine whether the diurnal changes in hip-
pocampal 5-HT2C receptor mRNA expression reflect changes in
the number of binding sites available and hence 5-HT2C receptor-
mediated neurotransmission, two behavioral tests for 5-HT2C
receptor agonist-mediated behavior were used (there are no ra-
dioligands that are sufficiently selective to discriminate 5-HT2A
and -2C receptor binding sites). It has been shown previously that
the 5-HT2C agonist mCPP inhibits locomotor activity in the open
field test (Kennett and Curzon, 1988a) and induces hypophagia
(Kennett and Curzon, 1988b). We found that mCPP-induced
inhibition of locomotor behavior and rearing in the open field test
exhibits a circadian periodicity, with inhibition more apparent at 9
A.M., which correlates well with the rhythm of hippocampal
5-HT2C receptor mRNA expression. mCPP inhibition of feeding,
however, an effect likely to be mediated by 5-HT2C receptors
outwith the hippocampus, showed no circadian rhythmicity, data
that concur with the lack of diurnal changes in 5-HT2C receptor
gene expression at most other brain sites and also suggest that the
diurnal rhythm observed in open field behavior is not attributable
to any diurnal variance in metabolism of the drug (which would
produce generalized effects). Thus it seems probable that the
diurnal rhythm in hippocampal 5-HT2C receptor mRNA expres-
sion is translated into a rhythm of 5-HT2C receptor protein and
hence 5-HT2C receptor-mediated behaviors.
Corticosterone
Chronic food restriction altered the normal diurnal profile of
plasma corticosterone, producing a biphasic rhythm with an extra
peak at 8 A.M. just before food availability, as well as the expected
rise at the beginning of the dark phase. Krieger and Hauser (1978)
have shown previously that food restriction has a potent influence
on the diurnal rhythm of plasma corticosterone. In this study,
plasma corticosterone levels over 24 hr were considerably greater
in food-restricted animals than in controls. Thus, the previously
reported HPA activation with short-term food restriction (Akana
et al., 1994) persists for several weeks. The marked if episodic
chronic hypersecretion of corticosterone suggests that long-term
food restriction is a model of chronic intermittent stress and hence
may be relevant for the study of molecular and other processes in
some affective and eating disorders.
5-HT2C receptors
We have demonstrated previously that glucocorticoids regulate
hippocampal 5-HT2C receptor mRNA expression (Holmes et al.,
1995a,b); however, the relationships are not straightforward.
Thus, the normal diurnal rhythm of hippocampal 5-HT2C receptor
gene expression persists in adrenalectomized rats (Holmes et al.,
1995b), implying that this is determined by factor(s) other than
the glucocorticoid rhythm, possibly associated with the light–dark
cycle cues. 5-HT2C receptor mRNA, however, is suppressed in the
hippocampus by continuously elevated glucocorticoids [at diurnal
maximum levels (Donaldson et al., 1993)] in chronic arthritis
stress (Holmes et al., 1995a). This suppression is also seen with
continuously but very modestly elevated corticosterone levels us-
ing low-dose pellets in this study, suggesting that whenever glu-
cocorticoids are persistently elevated above low basal levels they
suppress the rhythm of hippocampal 5-HT2C receptor mRNA (a
summary of the correlation of 5-HT2C receptor mRNA expression
in the hippocampus with plasma corticosterone profiles is pre-
sented in Fig. 9).
These effects of glucocorticoids, however, are clearly dependent
on the manner and timing of exposure. When corticosterone
levels were increased during the dark phase (mimicking the nor-
mal circadian rhythm), a normal rhythm in 5-HT2C receptor
mRNA was observed. This rhythm was abolished, with suppressed
receptor gene expression, if the same dose of corticosterone was
given with a peak in the daylight hours. These data suggest that a
nadir of corticosterone coinciding with the light-phase period of
inactivity is required for the normal nocturnal increase in hip-
pocampal 5-HT2C receptor mRNA. This contention is supported
by the effects of food restriction. This procedure did not suppress
the rhythm of 5-HT2C receptor mRNA expression in the hip-
pocampus, despite markedly elevated mean plasma corticosterone
levels. There was a clear diurnal nadir of corticosterone (;100
nmol / l) during the day, however, which thus may allow the later
rise of 5-HT2C receptor transcripts. Of course, providing the
mRNA is translated (data from the behavioral studies suggest that
this hypothesis is likely), then food restriction may inappropriately
maintain 5-HT2C receptor sensitivity in the face of chronic inter-
mittent stress and increased 5-HT transmission, perhaps amplify-
ing the deleterious actions on mood and behavior mediated by this
receptor subtype (Kennett et al., 1989, 1994). In contrast, contin-
uously elevated glucocorticoids or loss of the association between
the light–dark cycle and corticosterone suppresses the 5-HT2C
receptor rhythm and therefore presumably reduces the overall
sensitivity to activation of 5-HT2C receptors. Perhaps much
greater levels of stress or glucocorticoids are required under such
circumstances to overcome the “compensatory” decrease in re-
ceptor expression before adverse affective events may occur. The
food restriction protocol thus may be useful to investigate inter-
mittent stress or mismatch effects, perhaps as occur in depression
and eating disorders (Fig. 9).
The implications of the different effects of chronic intermittent
versus continuous glucocorticoid excess (i.e., stress vs Cushing’s
Figure 5. Plasma corticosterone levels obtained at 8 A.M. (08.00) and 8
P.M. (20.00) in sham-adrenalectomized (black and open columns) rats or
rats adrenalectomized with a 100 mg corticosterone slow-release pellet
subcutaneously (striped and stipled columns). *p , 0.05 compared with 8 A.M.
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disease or pharmacotherapy) on mood pathology remain to be
explored; however, increased 5-HT2C binding sites occur in ani-
mals exposed to chronic unpredictable stress (an animal model of
depression) when plasma corticosterone levels are allowed to
reach nadir levels between stresses (Moreau et al., 1993). Fur-
thermore, animals reared in isolation have increased sensitivity to
5-HT2C agonists (Fone et al., 1996), confirming in another model
of depression the importance of 5-HT2C receptor sensitivity. Pa-
tients with depression exhibit abnormal circadian rhythms of
plasma cortisol, with a prolonged peak and early timing of the
nadir, although a transient (or elevated) nadir usually occurs
(Linkowski et al., 1987). This nadir, however, may be sufficient to
maintain the diurnal rhythmicity and sensitivity of 5-HT2C recep-
tors in depression, even in the presence of elevated glucocorti-
coids. Moreover, there is a diurnal variation in performance of
various neuropsychological tasks in normal and depressed indi-
viduals; however, the variations are often reversed in patients with
depression (Moffoot et al., 1994). Some tasks, particularly those
involving short-term memory, are dependent on hippocampal
processing, and hence the diurnal expression of the 5-HT2C re-
ceptor may be an important factor in the production of these
diurnal differences.
5-HT2C receptor mRNA is also expressed in extra-hippocampal
sites, including the SCN, which generates /regulates diurnal
rhythms; however, we found high expression limited to a few cells
around the dorsal cap of the SCN, along with lower expression in
a subgroup of cells within the body of the nucleus. This distribu-
tion contrasts with very high expression throughout the SCN
reported by others (Roca et al., 1993). Whatever the cause of the
discrepancy, no circadian rhythm of receptor gene expression was
observed in any SCN subfield, and thus 5-HT2C receptors seem
unlikely to be directly involved in or responsive to SCN rhythms.
Most other loci of 5-HT2C receptor mRNA showed no diurnal
changes; the exceptions of the BNST and the PVN are discussed
below. The rhythm of 5-HT2C was selective in as far as no
circadian changes in 5-HT1A receptor mRNA expression in the
hippocampus were documented.
GR and MR rhythms
Both MR and GR mRNA expression in the hippocampus show
circadian variation (Herman et al., 1993; Holmes et al., 1995a),
findings confirmed here. A monophasic rhythm of both tran-
scripts was seen, with the data fitting better with other diurnal
processes (and the corticosterone rhythm) than the biphasic
rhythm of MR reported previously by Herman et al. (1993). GR
mRNA was clearly suppressed by the continuously if very
modestly elevated corticosterone levels with fixed-replacement,
suggesting sensitive autoregulation (Burnstein et al., 1991). In
Figure 6. The effect of constant corticosterone levels on the diurnal rhythm of (a) 5-HT2C receptor (5-HT2C R mRNA), (b) 5-HT1A receptor (5-HT1AR
mRNA), (c) MR (MR mRNA), and (d) GR (GR mRNA) mRNA expression in hippocampal subfields. Expression was measured in sham-operated animals
at 8 A.M. (black columns) and 8 P.M. (open columns) and compared with adrenalectomized rats with a corticosterone pellet at 8 A.M. (striped column)
and 8 P.M. (stipled column). Receptor mRNA levels were determined by in situ hybridization histochemistry. The mean number of grains /subregion /rat
was standardized to the expression observed in the control rats at 8 P.M. (100%). Values represent mean 6 SEM; n 5 5–6. *p , 0.05 compared with
value at 8 A.M. in sham-operated rats.
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food-restricted rats, however, there was clear divergence from
the expected inverse relationship between corticosterone levels
and GR gene expression, with overall hypersecretion of corti-
costerone associated with increased GR mRNA in CA1 at some
time points and maintained expression at all others. These data
suggest that the increase in GR gene expression reflects other
factors (stress, neurotransmitter release) in food restriction,
again producing a mismatch, this time between corticosteroid
receptors and their ligand. The MR mRNA rhythm was also
abolished by fixed-level corticosterone replacement, suggesting
that glucocorticoids are important; however, MR levels were
not reduced to the usual diurnal nadir and clearly other cues
are important in MR mRNA control. Again, food restriction
disrupted MR diurnal variation, effects that may interfere with
the normal MR-associated facilitation of hippocampal neuro-
nal activation (Joe¨ls and de Kloet, 1991). Why GR and MR
(and 5-HT2C receptors) in CA3 should be exempt from diurnal
variation and other regulatory influences in this study and
others remains an unexplored anomaly. The various promoters
of the MR gene show some site-specific expression and may
underlie such effects (Kwak et al., 1993).
HPA axis regulation
The highest hippocampal 5-HT2C receptor mRNA expression is in
ventral CA1 and the subiculum, areas showing circadian changes.
Efferents from the subiculum project to the PVN, either directly
(Kiss et al., 1983) or via the BNST (Herman et al., 1994). Lesion-
ing of the fimbria-fornix pathway to the BNST has been reported
to abolish the circadian rhythm of glucocorticoids (Fischette et al.,
1980), although this has been contested (Bradbury et al., 1993). It
is therefore possible that changes in subicular 5-HT2C receptor
activity could alter the recognized hippocampal regulation of
HPA axis activity (Jacobson and Sapolsky, 1991). Interestingly,
the BNST relay is also under serotonergic control, and here too
5-HT2C receptor mRNA is highly expressed and shows a diurnal
cycle. Moreover, the PVN expresses 5-HT2C receptor mRNA,
Figure 7. The effect of pulsatile corticosterone replacement on the diurnal rhythm of 5-HT2C receptor mRNA expression in ventral CA1 of the
hippocampus and plasma corticosterone levels. Sham-operated controls (M) compared with adrenalectomized rats with corticosterone replacement (F).
A, Sham-operated controls; B, corticosterone injection (20 mg/kg, s.c.) at 8 A.M. (8); C, corticosterone injection (20 mg/kg, s.c.) at 6 P.M. The arrow
represents time of corticosterone injection. Receptor mRNA levels were determined by in situ hybridization histochemistry. The mean number of
grains /subregion /rat was standardized to the expression observed in the control rats at 8 P.M. (20) (100%). Values represent mean 6 SEM; n 5 4. *p ,
0.05 compared with 8–10 A.M. control value. < p , 0.05 compared with 8–10 A.M. corticosterone replacement value. Time notation as in Figure 1 legend.
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again with a circadian variation, although this is opposite (highest
levels in the evening) to the hippocampus /subiculum and BNST
(highest in the morning). This may be relevant to the negative
influence of the hippocampus on the PVN. The pathway from the
BNST to the PVN is GABAergic and inhibitory (Herman et al.,
1994). Therefore, an increase in receptor number in the hip-
pocampus and BNST may reinforce a decrease in receptor num-
ber at the PVN.
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